HIV- 1 -specific CTL responses arise early during the course of infection, and persist at high frequencies, yet do not, in general, control HIV viremia. Although much is known about the magnitude of CTL responses to HIV epitopes comparatively little is known about the diversity of the TCR repertoire to immunodominant epitopes and how the breadth and avidity of this repertoire influences subsequent viremia. Over the previous funding period of this grant we have identified immunodominant CTL responses restricted by several HLA alleles, and have demonstrated that individual clonal CTL responses are able to persist in the host for prolonged periods. We have more recently combined our expertise in sequencing TCR genes with the ability to sort live, antigen-specific populations of CTL to assess the breadth of TCR repertoires to viral epitopes. We propose to determine whether the prompt generation of CTL with diverse TCR repertoires to dominant epitopes is associated with subsequent control of viremia in the absence of HAART. A diverse CTL repertoire is either more likely to cross-react with potential HIV- 1 variants, or is more likely to contain high-avidity CTL clones that are able to effectively suppress viral replication, in each case limiting the ability of HIV-1 to escape immune recognition. These studies will allow us to determine the relationship between the evolution of the TCR repertoire and immune control of viremia. Specifically we propose to: 1) Determine whether the TCR repertoires of immunodominant CTL responses in long-term nonprogressors are narrow due to the long-term selection of dominant clonal populations, or whether they are broad, thus limiting the potential generation of HIV-1 escape variants. 2) Determine whether the initial generation and maintenance of a diverse TCR repertoire is associated with control of viremia in subjects treated early after presentation with an acute retroviral syndrome. 3) Determine whether the generation of a diverse TCR repertoire contains cross-reactive CTL able to recognize potential HIV-1 escape variants. 4) Determine whether the generation of a diverse TCR repertoire contains populations of high-avidity CTL that come to dominate the population of CTL during chronic infection and mediate control of HIV- 1 replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI039966-11
Application #
7032266
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Finzi, Diana
Project Start
1997-04-01
Project End
2007-03-31
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
11
Fiscal Year
2006
Total Cost
$541,387
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Conrad, Joseph A; Ramalingam, Ramesh K; Duncan, Coley B et al. (2012) Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance. J Virol 86:4213-21
Conrad, Joseph A; Ramalingam, Ramesh K; Smith, Rita M et al. (2011) Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity. J Immunol 186:6871-85
Meyer-Olson, Dirk; Simons, Brenna C; Conrad, Joseph A et al. (2010) Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo. Blood 116:396-405
Sadagopal, Shanmugalakshmi; Lorey, Shelly L; Barnett, Louise et al. (2010) Enhanced PD-1 expression by T cells in cerebrospinal fluid does not reflect functional exhaustion during chronic human immunodeficiency virus type 1 infection. J Virol 84:131-40
Schneidewind, Arne; Tang, Yanhua; Brockman, Mark A et al. (2009) Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J Virol 83:8616-27
Antons, Amanda K; Wang, Rui; Kalams, Spyros A et al. (2008) Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals. PLoS One 3:e2952
Simons, Brenna C; Vancompernolle, Scott E; Smith, Rita M et al. (2008) Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants. J Immunol 181:5137-46
Sadagopal, Shanmugalakshmi; Lorey, Shelly L; Barnett, Louise et al. (2008) Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects. J Virol 82:10418-28
Oswald-Richter, Kyra; Grill, Stacy M; Leelawong, Mindy et al. (2007) Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog 3:e58
Martinez-Hackert, Erik; Anikeeva, Nadia; Kalams, Spyros A et al. (2006) Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes. J Biol Chem 281:20205-12

Showing the most recent 10 out of 28 publications